Business News • PR NewsWire • Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012

Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012

Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012

GREENWOOD VILLAGE, Colo., Nov. 28, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (AMPE), a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual...

View More : http://www.prnewswire.com/news-releases/ampio-pharmaceuticals-inc-ampe-announces-appointment-of-josh-disbrow-as-chief-op...

Releted News by prnewswire

China Nepstar Chain Drugstore Reports Third Quarter 2012 Financial Results

Publicis Groupe : Conseil du 27 novembre 2012

Publicis Groupe: Supervisory Board of November, 27th 2012

Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012

HNA Tourism Unveils First Luxury Cruise Ship in Mainland China

High Degree of Disease Prevalence Sustains Diabetes Diagnostics Market in Europe, Finds Frost & Sullivan